Shenzhen New Industries Biomedical Engineering financials at a glance

The revenue of Shenzhen New Industries Biomedical Engineering is reported as 3.92966 billion Yuan Renminbi in the fiscal year 2023. The earnings were 1.97 Yuan Renminbi per share in 2023, which was 24.68 higher than 2022. And about 1.09609 billion Yuan Renminbi are reported as free cash flow in the financials of Shenzhen New Industries Biomedical Engineering 2023. Dividends of 1 Yuan Renminbi per share were paid to shareholders of Shenzhen New Industries Biomedical Engineering stock SZSE:300832 in fiscal 2023.